Literature DB >> 14735111

Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic.

L Frazier1, S T Turner, G L Schwartz, A B Chapman, E Boerwinkle.   

Abstract

BACKGROUND: The renin-angiotensin-aldosterone (RAA) system regulates blood pressure (BP) levels and influences responses to antihypertensive medications. Variation in RAA system genes has been reported to influence interindividual differences in BP levels and the occurrence of hypertension (HTN).
METHODS: We evaluated the relationship between variation in genes of the RAA system and interindividual differences in BP response to a thiazide diuretic. Analyses were carried out in a race- and gender-specific manner in 255 unrelated hypertensive African-Americans (125 men and 130 women) and 246 unrelated hypertensive non-Hispanic Whites (133 men and 113 women).
RESULTS: The angiotensin II receptor (AT(1)R) A1166C and angiotensinogen G-6A polymorphisms had a significant effect on systolic BP response to the diuretic in African-American women. Multilocus analyses indicated that the effects of these genes combined additively to influence response. Results of a permutation test to adjust for multiple comparisons and the possible nonindependence among genotypes remained significant at the P=0.003 level.
CONCLUSIONS: Among African-American women, particular gene variations in the RAA system have additive effects on BP response to a thiazide diuretic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735111     DOI: 10.1038/sj.tpj.6500215

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  15 in total

Review 1.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

Review 2.  Personalized medicine for high blood pressure.

Authors:  Stephen T Turner; Gary L Schwartz; Eric Boerwinkle
Journal:  Hypertension       Date:  2007-04-30       Impact factor: 10.190

3.  Effect of AGTR1 and BDKRB2 gene polymorphisms on atorvastatin metabolism in a Mexican population.

Authors:  Sarahí Herrera-González; Denisse Aideé Martínez-Treviño; Marcelino Aguirre-Garza; Magdalena Gómez-Silva; Hugo Alberto Barrera-Saldaña; Rafael Baltazar Reyes León-Cachón
Journal:  Biomed Rep       Date:  2017-10-25

Review 4.  Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance.

Authors:  Donna K Arnett; Steven A Claas
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

5.  Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.

Authors:  Chengxian Guo; Q I Pei; Hongyi Tan; Zhijun Huang; Hong Yuan; Guoping Yang
Journal:  Biomed Rep       Date:  2014-12-02

Review 6.  Gene markers and antihypertensive therapy.

Authors:  Stephen T Turner; Gary L Schwartz
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

7.  Pharmacogenetics of cardiovascular drug therapy.

Authors:  Bas J M Peters; Olaf H Klungel; Anthonius de Boer; Bruno H Ch Stricker; Anke-Hilse Maitland-van der Zee
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 8.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

9.  The Angiotensin II Type 1 Receptor-Associated Protein Attenuates Angiotensin II-Mediated Inhibition of the Renal Outer Medullary Potassium Channel in Collecting Duct Cells.

Authors:  Juliano Zequini Polidoro; Nancy Amaral Rebouças; Adriana Castello Costa Girardi
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

Review 10.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.